- GAZYVA full Prescribing Information. South San Francisco, CA: Genentech USA, Inc.; September 2015.
INCLUDES HEAD-TO-HEAD DATA vs rituximab + Clb
In combination with chlorambucil (Clb) in first-line CLL1
(Injection, obinutuzumab, 10 mg)
Phone: 1 888 249 4918
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "Proceed" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech, Inc. does not recommend and does not endorse the content on any third-party Web sites. Your use of third-party Web sites is at your own risk and subject to the terms and conditions of use for such sites.